Journal profile · ONCOLOGY
World Cancer Research Journal
ISSN 2372-3416 · Verduci Editore · Italy
World Cancer Research Journal: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.3 (journal website); diamond open access (no APC); no APC; review about 8 weeks (community reports); 16 articles a year; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Consequently, the scope of the Journal is to inform the scientific community about all innovative aspects regarding cancer disease.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief Massimiliano BerrettaPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named Italy 57, United States 12, France 6, Poland 3, Mainland China 2 (99 members with a country) Editorial board ↗Publisher website ·
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePublisher website
Other: Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 0.3Publisher website ·
- Impact factor (publisher) 2023
- 12Publisher website ·
- Impact factor (publisher) 2022
- 12Publisher website ·
- CiteScore 2026-06
- 1.6LetPub ·
- SJR 2026-06
- 0.15LetPub ·
- SNIP 2026-06
- 0.16LetPub ·
- h-index
- 0OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 16LetPub ·
- Articles per year (publisher)
- 5Publisher website ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- case reportCase Reports present a notable medical case or series of related cases of particular interest to the field of cancer research. Case Reports can be accompanied b…Length not stated
- editorialAll contributions are initially handled by the Editor-in-Chief (EiC), who together with Associate Editors (AE) make the initial evaluation of the manuscript by …Length not stated
- meta-analysisMeta-analyses use statistical methods to combine data from multiple and systematically selected studies. These manuscripts should be based on a rigorous methodo…Length not stated
Policy excerpts from the journal's websiteAuthorship, License & copyright, Peer review, Preprints, Self-archiving
- Authorship Authorship and Copyright
All authors should have made substantial contributions to all of the following:
Source ↗Publisher website ·- License & copyright Authorship and Copyright
All authors should have made substantial contributions to all of the following:
Source ↗Publisher website ·- Peer review Editorial Process and Peer Review
All contributions are initially handled by the Editor-in-Chief (EiC), who together with Associate Editors (AE) make the initial evaluation of the manuscript by verifying whether it falls within the aims of the journal; the decision may then be peer-reviewing or rejected. To facilitate either authors or peer-reviewers, only those papers that seem most likely to meet our editorial criteria are sent …
Source ↗Publisher website ·- Preprints Preprint policy
Please note that WCRJ does not accept submission of manuscripts that have previously been made available online as a preprint on a preprint server or on the authors’ own website.
Source ↗Publisher website ·- Self-archiving Self-Archiving Policy
WCRJ allows authors to archive specific versions of their manuscripts in institutional, disciplinary, or personal repositories under the conditions described below.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Verduci Editore
- Country or region
- Italy
- Language
- English
- ISSN
- 2372-3416
- Official links
- Journal homepage ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about World Cancer Research Journal
What CAS zone is World Cancer Research Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, World Cancer Research Journal is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of World Cancer Research Journal?
The journal's website gives an impact factor of 0.3 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 1.6, h-index 0.
How long does peer review take at World Cancer Research Journal?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of World Cancer Research Journal based?
Of the 99 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are Italy (57), United States (12) and France (6). Counted from the institutions listed on the board page; for reference only.
Which databases index World Cancer Research Journal?
According to LetPub and DOAJ records, World Cancer Research Journal is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science; that list has not been checked against each database.
Is World Cancer Research Journal open access, and what is the APC?
World Cancer Research Journal is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .